Age-dependent Protein Abundance of Cytosolic Alcohol and Aldehyde Dehydrogenases in Human Liver
- PMID: 28607029
- PMCID: PMC5563927
- DOI: 10.1124/dmd.117.076463
Age-dependent Protein Abundance of Cytosolic Alcohol and Aldehyde Dehydrogenases in Human Liver
Abstract
Hepatic cytosolic alcohol and aldehyde dehydrogenases (ADHs and ALDHs) catalyze the biotransformation of xenobiotics (e.g., cyclophosphamide and ethanol) and vitamin A. Because age-dependent hepatic abundance of these proteins is unknown, we quantified protein expression of ADHs and ALDH1A1 in a large cohort of pediatric and adult human livers by liquid chromatography coupled with tandem mass spectrometry proteomics. Purified proteins were used as calibrators. Two to three surrogate peptides per protein were quantified in trypsin digests of liver cytosolic samples and calibrator proteins under optimal conditions of reproducibility. Neonatal levels of ADH1A, ADH1B, ADH1C, and ALDH1A1 were 3-, 8-, 146-, and 3-fold lower than the adult levels, respectively. For all proteins, the abundance steeply increased during the first year of life, which mostly reached adult levels during early childhood (age between 1 and 6 years). Only for ADH1A protein abundance in adults (age > 18 year) was ∼40% lower relative to the early childhood group. Abundances of ADHs and ALDH1A1 were not associated with sex in samples with age > 1 year compared with males. Known single nucleotide polymorphisms had no effect on the protein levels of these proteins. Quantification of ADHs and ALDH1A1 protein levels could be useful in predicting disposition and response of substrates of these enzymes in younger children.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.
Figures


Similar articles
-
Inhibition of human alcohol and aldehyde dehydrogenases by cimetidine and assessment of its effects on ethanol metabolism.Chem Biol Interact. 2013 Feb 25;202(1-3):275-82. doi: 10.1016/j.cbi.2012.11.016. Epub 2012 Dec 7. Chem Biol Interact. 2013. PMID: 23220590
-
Expression pattern, ethanol-metabolizing activities, and cellular localization of alcohol and aldehyde dehydrogenases in human large bowel: association of the functional polymorphisms of ADH and ALDH genes with hemorrhoids and colorectal cancer.Alcohol. 2012 Feb;46(1):37-49. doi: 10.1016/j.alcohol.2011.08.004. Epub 2011 Sep 22. Alcohol. 2012. PMID: 21940137
-
Alcohol Metabolism in the Progression of Human Nonalcoholic Steatohepatitis.Toxicol Sci. 2018 Aug 1;164(2):428-438. doi: 10.1093/toxsci/kfy106. Toxicol Sci. 2018. PMID: 29718361 Free PMC article.
-
Variations in alcohol-metabolizing enzymes in people of East Indian and African descent from Trinidad and Tobago.Alcohol Res Health. 2007;30(1):28-30. Alcohol Res Health. 2007. PMID: 17718398 Free PMC article. Review.
-
The Role of Alcohol Dehydrogenase in Drug Metabolism: Beyond Ethanol Oxidation.AAPS J. 2021 Jan 7;23(1):20. doi: 10.1208/s12248-020-00536-y. AAPS J. 2021. PMID: 33415501 Review.
Cited by
-
IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making.Toxics. 2022 May 1;10(5):232. doi: 10.3390/toxics10050232. Toxics. 2022. PMID: 35622645 Free PMC article. Review.
-
Ontogeny of Drug-Metabolizing Enzymes.Methods Mol Biol. 2021;2342:551-593. doi: 10.1007/978-1-0716-1554-6_18. Methods Mol Biol. 2021. PMID: 34272706 Review.
-
Changes in Protein Expression of Renal Drug Transporters and Drug-Metabolizing Enzymes in Autosomal Dominant Polycystic Kidney Disease Patients.Clin Pharmacol Ther. 2025 Sep;118(3):682-692. doi: 10.1002/cpt.3715. Epub 2025 May 15. Clin Pharmacol Ther. 2025. PMID: 40371605 Free PMC article.
-
Impaired Hepatic Vitamin A Metabolism in NAFLD Mice Leading to Vitamin A Accumulation in Hepatocytes.Cell Mol Gastroenterol Hepatol. 2021;11(1):309-325.e3. doi: 10.1016/j.jcmgh.2020.07.006. Epub 2020 Jul 19. Cell Mol Gastroenterol Hepatol. 2021. PMID: 32698042 Free PMC article.
-
Critical Issues and Optimized Practices in Quantification of Protein Abundance Level to Determine Interindividual Variability in DMET Proteins by LC-MS/MS Proteomics.Clin Pharmacol Ther. 2018 Apr;103(4):619-630. doi: 10.1002/cpt.819. Epub 2017 Sep 25. Clin Pharmacol Ther. 2018. PMID: 28833066 Free PMC article. Review.
References
-
- Alnouti Y, Klaassen CD. (2008) Tissue distribution, ontogeny, and regulation of aldehyde dehydrogenase (Aldh) enzymes mRNA by prototypical microsomal enzyme inducers in mice. Toxicol Sci 101:51–64. - PubMed
-
- Boberg M, Vrana M, Mehrotra A, Pearce RE, Gaedigk A, Bhatt DK, Leeder JS, Prasad B. (2017) Age-dependent absolute abundance of hepatic carboxylesterases (CES1 and CES2) by LC-MS/MS proteomics: application to PBPK modeling of oseltamivir in vivo pharmacokinetics in infants. Drug Metab Dispos 45:216–223. - PMC - PubMed
-
- Buervenich S, Carmine A, Galter D, Shahabi HN, Johnels B, Holmberg B, Ahlberg J, Nissbrandt H, Eerola J, Hellström O, et al. (2005) A rare truncating mutation in ADH1C (G78Stop) shows significant association with Parkinson disease in a large international sample. Arch Neurol 62:74–78. - PubMed
-
- de Jonge ME, Huitema AD, Rodenhuis S, Beijnen JH. (2005) Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet 44:1135–1164. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous